Review

Alcohol Withdrawal

Authors: Anton Manasco, BS, Shannon Chang, MD, Joseph Larriviere, MD, L. Lee Hamm, MD, Marcia Glass, MD

Abstract

Alcohol withdrawal is a common clinical condition that has a variety of complications and morbidities. The manifestations can range from mild agitation to withdrawal seizures and delirium tremens. The treatments for alcohol withdrawal include benzodiazepines, anticonvulsants, beta-blockers and antihypertensives. Although benzodiazepines are presently a first-line therapy, there is controversy regarding the efficacies of these medications compared with others. Treatment protocols often involve one of two contrasting approaches: symptom-triggered versus fixed-schedule dosing of benzodiazepines. We describe these protocols in our review and examine the data supporting symptom-triggered dosing as the preferred method for most patients in withdrawal.


The Clinical Institute Withdrawal Assessment for Alcohol scoring system for alcohol withdrawal streamlines care, optimizes patient management, and is the best scale available for withdrawal assessment. Quality improvement implications for inpatient management of alcohol withdrawal include increasing training for signs of withdrawal and symptom recognition, adding new hospital protocols to employee curricula, and ensuring manageable patient-to-physician and patient-to-nurse ratios.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Phillips S, Haycock C, Boyle D. Development of an alcohol withdrawal protocol. Clin Nurse Spec 2006; 20: 190–198.
 
2. Riddle E, Bush J, Tittle M, et al. Alcohol withdrawal: development of a standing order set. Crit Care Nurse 2010; 30: 38–47.
 
3. National Institute on Alcohol Abuse and Alcoholism five year strategic plan, FY07-11, alcohol across the lifespan. http://pubs.niaaa.nih.gov/publications/StrategicPlan/NIAAASTRATEGICPLAN.htm. Accessed May 13, 2012.
 
4. Dodd PR, Beckmann AM, Davidson MS, et al. Glutamate-mediated transmission, alcohol, and alcoholism. Neurochem Int 2000; 37: 509–533.
 
5. Hughes JR. Alcohol withdrawal seizures. Epilepsy Behav 2009; 15: 92–97.
 
6. Deleted in proof.
7. Monte R, Rabunal R, Casariego E, et al. Risk factors for delirium tremens in patients with alcohol withdrawal syndrome in a hospital setting. Eur J Intern Med 2009; 20: 690–694.
8. Stern TA. Alcohol-induced disorders. In: Stern TA, Rosenbaum JF, Fava M, et al., eds. Massachusetts General Hospital Comprehensive Clinical Psychiatry. 1st ed. New York: Mosby/Elsevier; 2008: 1059–1060.
9. Zahr NM, Kaufman KL, Harper CG. Clinical and pathological features of alcohol-related brain damage. Nat Rev Neurol 2011; 7: 284–294.
10. Mayo-Smith MF. Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. JAMA 1997; 278: 144–151.
11. Amato L, Minozzi S, Vecchi S, et al. Benzodiazepines for alcohol withdrawal. Cochrane Database Syst Rev 2010; 17: CD005064.
12. Weaver MF, Hoffman HK, Johnson RE, et al. Alcohol withdrawal pharmacotherapy for inpatients with medical comorbidity. J Addict Dis 2006; 25: 17–24.
13. DeCarolis DD, Rice KL, Ho L, et al. Symptom-driven lorazepam protocol for treatment of severe alcohol withdrawal delirium in the intensive care unit. Pharmacotherapy 2007; 27: 510–518.
14. Stanley KM, Worrall CI, Lunsford SI, et al. Experience with an adult alcohol withdrawal syndrome practice guideline in internal medicine patients. Pharmacotherapy 2005; 25: 1073–1083.
15. Daeppen JB, Gache P, Landry U, et al. Symptom-triggered vs fixed-schedule doses of benzodiazepine for alcohol withdrawal: a randomized treatment trial. Arch Intern Med 2002; 162: 1117–1121.
16. Saitz R, Mayo-Smith MF, Roberts MS, et al. Individualized treatment for alcohol withdrawal. A randomized double-blind controlled trial. JAMA 1994; 272: 519–523.
17. Hecksel KA, Bostwick JM, Jaeger TM, et al. Inappropriate use of symptom-triggered therapy for alcohol withdrawal in the general hospital. Mayo Clinic Proc 2008; 83: 274–279.
18. Hasin DS, Stinson FS, Ogburn E, et al. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 2007; 64: 830–842.
19. Hack J, Hoffman R, Nelson L. Resistant alcohol withdrawal: does an unexpectedly large sedative requirement identify these patients early? J Med Toxicol 2006; 2: 55–60.
20. Gold JA, Rimal B, Nola A, et al. A strategy of escalating doses of benzodiazepines and phenobarbital administration reduces the need for mechanical ventilation in delirium tremens. Crit Care Med 2007; 35: 724–730.
21. Spies CD, Otter HE, Huske B, et al. Alcohol withdrawal severity is decreased by symptom-orientated adjusted bolus therapy in the ICU. Intens Care Med 2003; 29: 2230–2238.
22. Elholm B, Larsen K, Hornnes N, et al. Alcohol withdrawal syndrome: symptom-triggered versus fixed-schedule treatment in an outpatient setting. Alcohol Alcohol 2011; 46: 318–323.